NEWSROOM

July 14, 2025

Uniquity Bio Welcomes Will Kane as President and CEO

June 25, 2025

Solrikitug Shows Promise as Next-Generation Anti-TSLP Therapy in Asthma, COPD

June 12, 2025

Philadelphia Makes Biggest Leap of Any City in 2025 Rankings of World's Top Startup Ecosystems

May 1, 2025

Uniquity Bio Welcomes Bill Meury as Chairman

April 30, 2025

Building Uniquity Bio: Teams, Capital, And Strategy

April 29, 2025

Big Pharma Insights For Building Biotech Startups With Uniquity Bio's Brian Lortie

April 24, 2025

Giving promising drug compounds a second chance

March 12, 2025

25 Years in pharma: How one leader transforms companies and teams

January 2, 2025

A look at biotech's year of the megaround

December 31, 2024

Philly’s year in biopharma: a look back at 2024

December 9, 2024

Blackstone Eyes $5 Billion for Life Sciences Investments

September 19, 2024

Six immunology biotech companies revolutionizing immune treatments in 2024

July 3, 2024

In biotech's uneven recovery, 50 startups raised megarounds in first half of 2024

May 28, 2024

Uniquity Bio's CEO on exiting stealth mode with $300M in funding from its parent Blackstone to go after TSLP in the I&I space

May 15, 2024

Blackstone unearths Uniquity Bio with $300M to explore Merck drug's I&I potential

May 15, 2024

Blackstone Life Sciences Launches Uniquity Bio to Develop Novel Medicines in Immunology & Inflammation